EFFICACY OF TEZEPELUMAB IN PATIENTS WITH LOW AND HIGH BRONCHODILATOR REVERSIBILITY IN PATHWAY

被引：0
|
作者：
Corren, J. [1 ]
Liu, M. C. [2 ]
Bowen, K. [3 ]
Salapa, K. [4 ]
Colice, G. [3 ]
Llanos-Ackert, J. P. [5 ]
机构：
[1] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA
[2] Johns Hopkins Asthma & Allergy Ctr, Baltimore, MD USA
[3] AstraZeneca, Gaithersburg, MD USA
[4] AstraZeneca, Warsaw, Poland
[5] Amgen Inc, Thousand Oaks, CA USA
来源：
THORAX | 2021年 / 76卷
关键词：
D O I：
10.1136/thorax-2020-BTSabstracts.144
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
S139
引用
收藏
页码：A83 / A84
页数：2
相关论文
共 50 条
  • [1] Efficacy of tezepelumab in patients with low and high bronchodilator reversibility in PATHWAY
    Corren, J.
    Liu, M. C.
    Bowen, K.
    Salapa, K.
    Colice, G.
    Llanos-Ackert, J. P.
    PNEUMOLOGIE, 2021, 75 : S37 - S38
  • [2] Efficacy of tezepelumab in patients with low and high bronchodilator reversibility in PATHWAY
    Corren, Jonathan
    Liu, Mark C.
    Bowen, Karin
    Salapa, Kinga
    Colice, Gene
    Llanos-Ackert, Jean-Pierre
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [3] TEZEPELUMAB EFFICACY ACCORDING TO BRONCHODILATOR REVERSIBILITY IN PATIENTS WITH SEVERE, UNCONTROLLED ASTHMA IN NAVIGATOR
    Menzies-Gow, A.
    Bourdin, A.
    Korn, S.
    Cook, B.
    Ambrose, C.
    Ponnarambil, S.
    Hunter, G.
    Molfino, N.
    Colice, G.
    Llanos-Ackert, J.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2021, 127 (05) : S37 - S37
  • [4] BRONCHODILATOR REVERSIBILITY TO LOW AND HIGH-DOSES OF TERBUTALINE AND IPRATROPIUM IN COPD
    NEWNHAM, DM
    CLARK, RA
    DHILLON, DP
    WINTER, JH
    JACKSON, CM
    LIPWORTH, BJ
    THORAX, 1992, 47 (03) : P255 - P256
  • [5] Efficacy of Levosalbutamol/Ipratropium Combination in Early Bronchodilator Reversibility
    Iyigun, Ozgun
    Uzar, Tugce
    Karaman, Irem
    Dirican, Adem
    Ozkaya, Sevket
    JOURNAL OF PHARMACEUTICAL RESEARCH INTERNATIONAL, 2020, 32 (28) : 87 - 92
  • [6] Efficacy of Tezepelumab in Black or African American Patients: A Pooled Analysis of The PATHWAY and NAVIGATOR Studies
    Rhoads, S.
    Wechsler, M. E.
    Trevor, J.
    Moore, W.
    Llanos, J.
    Martin, N.
    Spahn, J. D.
    Ambrose, C. S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [7] BRONCHODILATOR REVERSIBILITY TO LOW AND HIGH-DOSES OF TERBUTALINE AND IPRATROPIUM BROMIDE IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY-DISEASE
    NEWNHAM, DM
    DHILLON, DP
    WINTER, JH
    JACKSON, CM
    CLARK, RA
    LIPWORTH, BJ
    THORAX, 1993, 48 (11) : 1151 - 1155
  • [8] BRONCHODILATOR AND CORTICOSTEROID REVERSIBILITY IN AMBULATORY PATIENTS WITH AIRWAYS OBSTRUCTION
    DIRKSEN, A
    CHRISTENSEN, H
    EVALD, T
    JENSEN, BV
    JENSEN, JI
    KEITTELMANN, S
    VESTBO, J
    KOKJENSEN, A
    DANISH MEDICAL BULLETIN, 1991, 38 (06): : 486 - 489
  • [9] Bronchodilator reversibility in patients with asthma and persistent airflow limitation
    Crisafulli, Ernesto
    Sartori, Giulia
    Patruno, Vincenzo
    Fantin, Alberto
    LANCET RESPIRATORY MEDICINE, 2022, 10 (11): : E94 - E95
  • [10] EFFICACY OF TEZEPELUMAB IN PATIENTS WITH ASTHMA AND PERSISTENT AIRFLOW OBSTRUCTION: A POOLED ANALYSIS OF THE PATHWAY AND NAVIGATOR STUDIES
    Israel, Elliot
    Castro, Mario
    Martin, Nicole
    Ambrose, Christopher
    Ackert, Jean-Pierre Llanos
    Cook, William
    Molfino, Nestor
    Ponnarambil, Sandhia
    CHEST, 2023, 164 (04) : 15A - 17A
12345